Opinions
Jason Snipe, CIO, Odyssey Capital Advisors
Alnylam Pharmaceuticals
ALNY-Q
BUY
Jun 24, 2024
$222.820
Stock price when the opinion was issued
biotechnology
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
Positive results of their heart disease drug lifted shares today. M&A in this space and declining interest rates have been positive. We'll see what happens here. Drug pricing is always an issue in election years, but he thinks this will do well this year.